Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative

• Κύριοι συγγραφείς: Muh. Akbar Bahar (Συγγραφέας), Jens H. J. Bos (Συγγραφέας), Sander D. Borgsteede (Συγγραφέας), Aafje Dotinga (Συγγραφέας), Rolinde A. Alingh (Συγγραφέας), Bob Wilffert (Συγγραφέας), Eelko Hak (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

BackgroundDrug-drug interaction (DDI) is one of the main contributors to adverse drug reactions and therefore, it is important to study its frequency in the population. We aimed to investigate frequency and concordance on CYP2D6, CYP2C19, and CYP2C9 (CYP2D6/2C19/2C9)-mediated potential DDIs at the L...